已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer

医学 阶段(地层学) 肺癌 放射治疗 肿瘤科 放射科 生物 古生物学
作者
Robert D Timmerman,Rebecca Paulus,Harvey Ira Pass,Elizabeth Gore,Martin J. Edelman,James M. Galvin,William L. Straube,Lucien Alexander Nedzi,Ronald C. McGarry,Clifford G. Robinson,Peter B. Schiff,Garrick C. Chang,Billy Wiseman Loo Jr.,Jeffrey D. Bradley,Hak Choy
出处
期刊:JAMA Oncology [American Medical Association]
卷期号:4 (9): 1263-1263 被引量:373
标识
DOI:10.1001/jamaoncol.2018.1251
摘要

Importance: Stereotactic body radiation therapy (SBRT) has become a standard treatment for patients with medically inoperable early-stage lung cancer. However, its effectiveness in patients medically suitable for surgery is unclear. Objective: To evaluate whether noninvasive SBRT delivered on an outpatient basis can safely eradicate lung cancer and cure selected patients with operable lung cancer, obviating the need for surgical resection. Design, Setting, and Participants: Single-arm phase 2 NRG Oncology Radiation Therapy Oncology Group 0618 study enrolled patients from December 2007 to May 2010 with median follow-up of 48.1 months (range, 15.4-73.7 months). The setting was a multicenter North American academic and community practice cancer center consortium. Patients had operable biopsy-proven peripheral T1 to T2, N0, M0 non-small cell tumors no more than 5 cm in diameter, forced expiratory volume in 1 second (FEV1) and diffusing capacity greater than 35% predicted, arterial oxygen tension greater than 60 mm Hg, arterial carbon dioxide tension less than 50 mm Hg, and no severe medical problems. The data analysis was performed in October 2014. Interventions: The SBRT prescription dose was 54 Gy delivered in 3 18-Gy fractions over 1.5 to 2.0 weeks. Main Outcomes and Measures: Primary end point was primary tumor control, with survival, adverse events, and the incidence and outcome of surgical salvage as secondary end points. Results: Of 33 patients accrued, 26 were evaluable (23 T1 and 3 T2 tumors; 15 [58%] male; median age, 72.5 [range, 54-88] years). Median FEV1 and diffusing capacity of the lung for carbon monoxide at enrollment were 72.5% (range, 38%-136%) and 68% (range, 22%-96%) of predicted, respectively. Only 1 patient had a primary tumor recurrence. Involved lobe failure, the other component defining local failure, did not occur in any patient, so the estimated 4-year primary tumor control and local control rate were both 96% (95% CI, 83%-100%). As per protocol guidelines, the single patient with local recurrence underwent salvage lobectomy 1.2 years after SBRT, complicated by a grade 4 cardiac arrhythmia. The 4-year estimates of disease-free and overall survival were 57% (95% CI, 36%-74%) and 56% (95% CI, 35%-73%), respectively. Median overall survival was 55.2 months (95% CI, 37.7 months to not reached). Protocol-specified treatment-related grade 3, 4, and 5 adverse events were reported in 2 (8%; 95% CI, 0.1%-25%), 0, and 0 patients, respectively. Conclusions and Relevance: As given, SBRT appears to be associated with a high rate of primary tumor control, low treatment-related morbidity, and infrequent need for surgical salvage in patients with operable early-stage lung cancer. Trial Registration: ClinicalTrials.gov Identifier: NCT00551369.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊的铭的应助被潇洒的代双采纳,获得10
刚刚
刚刚
叹千泠完成签到,获得积分10
1秒前
完美世界的应助被包容耳机采纳,获得30
2秒前
2秒前
xiaoyangjuejue完成签到,获得积分10
3秒前
风吹麦浪的应助被星辰大海采纳,获得10
3秒前
简单寒天发布了新的文献求助10
3秒前
edisonzz发布了新的文献求助30
3秒前
randomname完成签到,获得积分10
6秒前
6秒前
搜集达人的应助被江就采纳,获得10
7秒前
情怀的应助被隐形的凡阳采纳,获得10
7秒前
7秒前
深情安青的应助被蕾蕾采纳,获得30
8秒前
8秒前
9秒前
9秒前
cz完成签到 ,获得积分10
9秒前
哈哈哈发布了新的文献求助30
11秒前
阳光完成签到,获得积分10
11秒前
CC发布了新的文献求助10
12秒前
12秒前
KTV发布了新的文献求助10
12秒前
Xi完成签到 ,获得积分10
12秒前
JOJO发布了新的文献求助10
13秒前
ZYLLYL完成签到,获得积分10
14秒前
14秒前
CodeCraft的应助被Roy007采纳,获得10
15秒前
111完成签到,获得积分10
15秒前
我是老大的应助被冬雾采纳,获得10
15秒前
16秒前
四旬完成签到,获得积分10
16秒前
外向大楚完成签到,获得积分10
17秒前
18秒前
张三完成签到,获得积分10
18秒前
慕青的应助被Bai采纳,获得10
19秒前
苏景烟发布了新的文献求助20
19秒前
小二郎的应助被szxa采纳,获得10
19秒前
爱科研的小王同学完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179129
求助须知:如何正确求助?哪些是违规求助? 9569710
关于积分的说明 21806324
捐赠科研通 7774507
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556912
邀请新用户注册赠送积分活动 2478649